Articles - Page 64 of 92 - Drugs in Context

Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

Rudolf Hoermann, John E M Midgley, Rolf Larisch, Johannes W Dietrich

Article Type

Review

Published

13 Aug 2019

This review discusses levothyroxine therapy in the alleviation of hypothyroidism, focusing on complex needs, the available options and setpoints.

New uses and formulations of glucagon for hypoglycaemia

Pilar I Beato-Víbora PhD, Francisco J Arroyo-Díez PhD

Article Type

Review

Published

30 Jul 2019

Hypoglycaemia is a frequent complication of insulin
therapy. Injectable glucagon and oral intake of carbohydrates are
the recommended treatments for severe and non-severe
hypoglycaemic episodes, respectively. New uses and formulations of glucagon are reviewed and discussed in this article.

Targeting eosinophils: severe asthma and beyond

Marco Caminati MD, Francesco Menzella MD, Lucia Guidolin MD, Gianenrico Senna MD

Article Type

Review

Published

23 Jul 2019

This review summarizes the rationale for the use of biologics in eosinophilic diseases and their mechanisms of action.

Palbociclib in metastatic breast cancer: current evidence and real-life data

Francesco Serra MD, Pietro Lapidari MD, Erica Quaquarini MD, Barbara Tagliaferri MD, Federico Sottotetti MD, Raffaella Palumbo MD, PhD

Article Type

Review

Published

16 Jul 2019

This review summarizes the background and latest evidence for the use of palbociclib, an oral, first-in-class, highly selective cyclin-dependent kinase 4/6 inhibitor, in advanced breast cancer, with a focus on some of the unanswered questions about the performance of this agent in clinical practice.

Guselkumab for the treatment of psoriasis – evidence to date

Miguel Nogueira MD, Tiago Torres MD, PhD

Article Type

Review

Published

09 Jul 2019

This review highlights the evidence available to date for the use of guselkumab for the treatment of psoriasis. The results of the recent ECLIPSE trial are addressed.